Ready to build your own Founder-Led Growth engine? Book a Strategy Call
Frontlines.io | Where B2B Founders Talk GTM.
Strategic Communications Advisory For Visionary Founders
As a medical device company, Feedback must balance the desire to move quickly and iterate based on customer feedback with the need to prioritize patient safety and risk management. Dr. Oakley highlights the importance of developing a unique skill set that allows for agile development within a regulated environment.
While being a public company brings added scrutiny and pressure from shareholders, Dr. Oakley emphasizes the importance of staying focused on delivering value to customers and sitting close to their needs. By prioritizing product quality and user experience, the team can drive long-term growth and trust that the share price will follow.
The rigorous certification process for medical devices can be a barrier to entry, but it also creates opportunities to differentiate from both larger competitors and smaller startups. By leveraging its status as a certified platform for image display and collaboration, Feedback can tackle challenges and integrate systems in ways that others cannot.
Selling technology into healthcare, particularly in the NHS, requires a high degree of persistence and discipline. With decision-making often involving multiple stakeholders and lengthy procurement processes, founders must be prepared to engage repeatedly and chase opportunities relentlessly to close deals.
The COVID-19 pandemic accelerated the adoption of remote collaboration tools in healthcare, and Feedback seized this opportunity to enable clinicians to treat patients across vast distances. As the company expands internationally, it envisions a future where its platform can serve as a "digital glue" connecting care settings and deploying innovative technologies on a global scale.
How Feedback PLC Turned Medical Device Constraints Into a Blue Ocean Opportunity
The most interesting pivots often come from seeing opportunity where others see constraints. In a recent episode of Category Visionaries, Thomas Oakley shared how he transformed a declining 20-year-old medical imaging company into a high-growth clinical collaboration platform by embracing the very regulations that others saw as limitations.
When Thomas took the helm of Feedback PLC in 2019, he inherited a company that had been “over promised and often under delivered” to shareholders. Their legacy medical imaging products were being overtaken by industry giants like GE, Phillips, and Siemens, creating what seemed like an impossible competitive situation.
But rather than try to compete head-on, Thomas saw an opportunity to leverage their medical device certification in an entirely new direction. “The medical device has both a real term advantage for us, but also creates that slight friction because we can’t be as agile as we’d like to because we have to conform to quality standards as we develop the product,” he explains.
This apparent constraint became their competitive moat. While other companies could build chat interfaces or integration tools, none could combine these with certified medical image viewing capabilities. As Thomas notes, “We are certainly in the UK, the only clinical collaboration platform that is certified as medical device for image display.”
This positioning unlocked entirely new markets. They were selected to run “the UK’s first end-to-end care pathway between GPs in primary care hospitals, in secondary care, and these new community diagnostic centers.” Why? Because they were “the only provider that had the capability to stitch the IT infrastructure together in the background and then present it in a collaboration environment.”
Building in a Regulated Environment
The team had to solve a fundamental tension between agile development and medical device requirements. As Thomas explains, “If you are developing software in an agile way, you rapidly create a new version of a product, see what works, see what doesn’t, and then iterate those changes back into your product. You can’t do that in a clinical environment where if you get something wrong or there’s a bug in your software that could have an impact on patients.”
Their solution was developing a unique approach to regulated agile development. Instead of rapid iteration, they “risk assess everything that you’re doing, anticipate risk and try and remove it from the product before you ever put it into the hands of clinicians.” This created a high barrier to entry while still enabling customer-driven development.
The Sales Marathon
The sales cycle reflects the complexity of selling into healthcare environments. Thomas is candid about the persistence required: “It takes anywhere between ten to thirty engagements before you get to the point of contracting. Then you typically go through procurement, and that procurement process can take six to nine months.”
Rather than trying to shortcut this process, they embraced it. The team maintains an “absolute obsession with sitting close to the customer,” using their input to drive product iterations. During COVID, this led them to develop capabilities allowing consultants to treat patients in Manchester while being at home with family in Delhi.
This customer-centric approach extended internationally through strategic partnerships. Working with AWS and an AI company called Cure AI, they adapted their technology to enable TB screening in rural India. By developing capabilities to push imaging over mobile networks – originally created for veterinary use in the UK – they enabled “AI-powered TB screening diagnosis within about 30 seconds of an x-ray being taken anywhere in India where you had 3G connectivity.”
The Results
The transformation has delivered consistent 74% year-over-year growth for three years running, with an 89% increase in sales in their latest period. More importantly, they’ve demonstrated the ability to reduce patient wait times in the NHS by 70% without adding clinical staff.
Looking ahead, Thomas sees their technology becoming “essentially a digital glue that pulls healthcare environments together and through party technologies can be deployed to a national or international healthcare audience.” By embracing rather than fighting regulatory constraints, they’ve created a unique position in healthcare technology – one that larger competitors can’t easily replicate and smaller ones can’t easily enter.
The lesson for founders? Sometimes the most promising go-to-market opportunities come not from avoiding constraints, but from turning them into competitive advantages that others can’t easily replicate.
CEO and Co-Founder of Corti
Andreas Cleve, CEO and Co-Founder of Corti: $32 Million Raised to Power the Future of Patient Consultations
Co-Founder and CEO of Inato
Kourosh Davarpanah, Co-Founder and CEO of Inato: Over $35 Million Raised to Build the Future of Clinical Trials
Founder and CEO of Trial Library
Hala Borno, Founder and CEO of Trial Library: $5M Raised to Improve Patient Recruitment and Diversity in Oncology Clinical Trials
CEO & Founder of Epitel
Mark Lehmkuhle, CEO & Founder of Epitel: $20 Million Raised to Build the Future of Brain Health Monitoring
Founder of Akston Biosciences
Todd Zion, Founder of Akston Biosciences: From a $500M Exit to Pioneering Biotech Innovation in Pet Health
CEO of Datacubed Health
Brett Kleger, CEO of Datacubed Health: $43 Million Raised to Revolutionize Clinical Trial Data Collection
VP of Marketing of Healthee
Why AI Should Enhance, Not Replace Your Marketing Team
President and Founder of Narrativa
How Narrativa leveraged COVID-19 as a market catalyst to accelerate AI adoption in pharma | Jennifer Bittinger ($2.4M Raised)
Founder of GigXR
David King Lassman, Founder of GigXR: $7 Million Raised to Bring Immersive Learning to Healthcare
CEO of Arrive Health
Kyle Kiser, CEO of Arrive Health: Over $40 Million Raised to Improve the Value of Healthcare Through Informed Decision-Making
Mastering Market Fit in AI: Insights from Michael Chang, Director of Marketing at ArteraAI
CEO of Prospection
Daniel West, CEO of Prospection: $36 Million Raised to Build the Future of Patient-Centric Intelligence
Senior Marketing Manager of Amenities Health
Humanizing Healthcare Tech: Marketing Lessons from Amenities
CEO of Identifeye Health
Vicky Demas, CEO of identifeye HEALTH: $90 Million Raised to Power the Future of Retinal Imaging
CEO and Founder of AdviNOW Medical
James Bates, CEO and Founder of AdviNOW Medical: $24 Million Raised to Build the Future of AI-Powered Healthcare
CEO and Co-Founder of CEO and Co-Founder
Alfred Griffin, CEO and Co-Founder of LightForce: $150 Million Raised to Power the Future of Orthodontics
CEO and Co-Founder of Socially Determined
Trenor Williams, CEO and Co-Founder of Socially Determined: $34 Million Raised to Build the Social Risk Intelligence Category
CEO and Co-Founder of Sorcero
Dipanwita Das, CEO and Co-Founder of Sorcero: Over $20 Million Raised to Power Medical Affairs Teams of the Future
CEO and Founder of Authenticx
Amy Brown, CEO and Founder of Authenticx: $28 Million Raised to Build the Future of Listening AI
Co-Founder & Chief Executive Officer of Dexcare
Derek Streat, CEO of Dexcare: $110 Million Raised to Help Health Systems to Find Time for the Best Care
CEO & Co-Founder of Synthpop
Elad Ferber, CEO & Co-Founder of Synthpop: $8 Million Raised to Build the Future of Healthcare Administration with AI
Director of Growth of Nelly Solutions
How Nelly Grew 3X Through Meta Ads in Health Tech
CEO and Co-Founder of DignifiHealth
Richard Queen, CEO and Co-Founder of DignifiHealth: $7 Million Raised to Drive Better Patient Outcomes in Rural Healthcare and Beyond
CEO & Founder of Blueprint
Danny Freed, CEO & Founder of Blueprint: $13.7 Million Raised to Build the Future of Therapist Enablement
CEO and Co-Founder of Gradient Health
Joshua Miller, CEO & Co-Founder of Gradient Health: $5.7 Million Raised to Build the Future of Medical Imaging
CEO of Anomaly
Why Anomaly avoids annual curiosity revenue (ACR) — and you probably should to | Mike Desjadon ($30M Raised)
CEO and Co-Founder of Yuvo Health
Cesar Herrera, CEO and Co-Founder of Yuvo Health: $28 Million Raised to Revolutionize Healthcare Access
CEO & Co-Founder of Upfront Healthcare
Ben Albert, CEO & Co-Founder of Upfront Healthcare: $30 Million Raised to Power the Future of Patient Engagement
CEO and Founder of Aclid
Kevin Flyangolts, CEO & Founder of Aclid: $4 Million Raised to Build the Future of Biosecurity
Co-Founder & CEO of Lynx
Matt Renfro, CEO of Lynx: $17.5 Million raised to Bring Modern Fintech to Healthcare
CEO & Founder of Decent
Nick Soman, CEO & Founder of Decent: $43 Million Raised to Build the Future of Direct Primary Care
CEO and Co-Founder of Thoughtful AI
Alex Zekoff, CEO and Co-Founder of Thoughtful AI: $21 Million Raised to Power the Future of Healthcare Automation
CEO & Founder of Ansel Health
Veer Gidwaney, CEO & Founder of Ansel Health: $50 Million Raised to Transform Supplemental Health Insurance
CEO & Co-Founder of StretchDollar
How StretchDollar drives leads from LLM search | Marshall Darr
CEO & Founder of B.well
Kristen Valdes, CEO & Founder of B.well: $100 Million Raised to Reimagine the Healthcare Experience
CEO and Founder of Valo
David Berry, CEO and Founder of Valo: Over $500 Million Raised to Build the Future of Drug Discovery
Founder and CEO of Radish Health
Viral Patel, CEO of Radish Health: $5 Million Raised to Connect Employees with a Better Healthcare Experience
Head of Marketing of Intelligencia AI
Beyond Perfect: Healthcare Tech Marketing That Drives Real Revenue
CEO & Co-Founder of Uptiv Health
Torben Nielsen, CEO of Uptiv Health: $7.5M Raised to Build the Future of Infusion Therapy Through Technology-Enabled Retail Centers
CEO of Trusty Care
Joseph Schneier, CEO of Trusty Care: $13+ Million Raised to Shape the Future of Medicare
Founder and CEO of Phamily
How Phamily built an eight-figure ARR healthcare company without discounting: The subsidized R&D approach | Nabeel Kaukab ($25M Raised)
Co-Founder and CEO of PayZen
Itzik Cohen, Co-Founder and CEO of PayZen: $240 Million Raised to Build the Future of Affordable Health Care
Founder & CMO of Savana
Ignacio Medrano, Founder & CMO of Savana: $44M Raised to Transform Healthcare Intelligence Through AI
CEO & Co-Founder of Brightside
Brad Kittredge, CEO & Co-Founder of Brightside: $150 Million Raised to Build the Future of Mental Healthcare
CEO of SocialClimb
Ty Allen, CEO of SocialClimb: $12 Million Raised to Power the Future of Healthcare Marketing
CEO & Co-Founder of Siftwell Analytics
Trey Sutten, CEO & Co-Founder of Siftwell Analytics: $5 Million Raised to Transform Healthcare Analytics with AI-Powered Predictions
CEO & Co-Founder of Intelligencia AI
Dimitrios Skaltsas, CEO & Co-Founder of Intelligencia AI: $15.5 Million Raised to Build the Future of Drug Development
CEO and Co-Founder of Venteur
Stacy Edgar, CEO & Co-Founder of Venteur: $7.6 Million Raised to Build the Future of Health Insurance
CEO & Founder of Canary Speech
Henry O’Connell, CEO & Founder of Canary Speech: $26 Million Raised to Build the Future of Vocal Biomarker Technology
CEO of DermaSensor
Cody Simmons, CEO of DermaSensor: $36 Million Raised to Build the First AI-Powered Skin Cancer Detection Tool for Primary Care
CEO of Casana
Austin McChord, CEO of Casana: Over $46 Million Raised to Create the Future of In-Home Health Monitoring
CEO and Co-Founder of Zivian Health
Rafid Fadul, CEO and Co-Founder of Zivian Health: $3 Million Raised to Power the Future of Compliant Healthcare Collaborations
CEO & Founder of Portal
Armon Sharei, CEO & Founder of Portal: $5 Million Raised to Power the Future of Cell Engineering
President and Co-Founder of Homeward
Amar Kendale, President & Co-Founder of Homeward: $70 Million Raised to Transform Rural Healthcare Through Technology
CEO of 1upHealth
Joe Gagnon, CEO at 1upHealth: Over $75 Million Raised to Build the Future of Healthcare Data
Marketing & Sales Enablement Lead of FIGUR8
Integrity-Driven Marketing: FIGUR8’s Path to 3,000+ Clinics
CEO and Founder of FIGUR8
Dr. Nan-Wei Gong, CEO & Founder of FIGUR8: $40 Million Raised to Build the Future of Musculoskeletal Health and Injury Data Solutions
CEO of PathologyWatch
Daniel Lambert, CEO of PathologyWatch: Over $50 Million Raised to Build the Future of Digital Pathology
Founder of Teladoc
Teladoc Founder Michael Gorton on the Early Days of Pioneering the Telemedicine Category (And What’s He’s Up to Next)
CEO & Founder of VitVio
Thomas Knox, CEO & Founder of VitVio: $10 Million Raised to Transform Surgical Operations Through AI-Powered Automation
CEO and Founder of AppliedVR
Matthew Stoudt, CEO and Founder of AppliedVR: Over $70 Million Raised to Build the Future of Chronic Pain Relief
Founder & CEO of Praia Health
Justin Dearborn, Founder & CEO of Praia Health: $20 Million Raised to Build the Future of Consumer Experience in Healthcare
CEO of Trek Health
Dilpreet Sahota, CEO of Trek Health: $3 Million Raised to Help Mental Health Providers Accept Insurance
CEO & Co-Founder of Prescribe FIT
Brock Leonti, CEO & Co-Founder of Prescribe FIT: $15 Million Raised to Build the Future of Orthopedic Care
CEO & Founder of Delfina
Senan Ebrahim, CEO & Founder of Delfina: $10 Million Raised to Build the Future of Intelligent Pregnancy Care
Co-Founder and CEO of HealthSnap
Samson Magid, Co-Founder and CEO of HealthSnap: Over $12 Million Raised to Build the Future of Remote Patient Monitoring
CEO and Co-Founder of PocketHealth
Rishi Nayyar, CEO and Co-Founder of PocketHealth: $22.5 Million Raised to Power the Future of Medical Image Sharing
CEO and Founder of Amenities Health
Aasim Saeed, CEO and Founder of Amenities Health: $10 Million Raised to Build the Future of Patient Engagement
Founder of Torch Dental
Khaled Boukadoum, Founder of Torch Dental: $49.5 Million Raised to Transform Dental Supply Management Through Digital Innovation
Senior Vice President of Marketing and Communications of Capital Rx
How to Build 18-Month Attribution Models That Actually Work